Matthias Von Herrath's guest appearances

Matthias Von Herrath

Diabetes Research Center - Seminar Series

Pardon My Pancreas - Type 1 Diabetes with Matt Vande Vegte

TheSugarScience Podcast- curating the scientific conversation in type 1 diabetes

Christine Bender

Robby Barbaro

Stephen Gray

Sarah Richardson

Johns Hopkins

DAVID WAGNER

Howard Hughes

Yong Zhao

Lucy Walker

Jerry Nadler

John Glass

Noel G

Robert Lewis

Steve Willi

Michael Rickels

OwlTail

In this episode, Dr. Matthias von Herrath joins us to discuss his work at the La Jolla Institute for Immunology and at pharmaceutical company Novo Nordisk. He discusses one of his recently published papers, "Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial".  Full paper link: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00019-X/fulltext 

In this episode, Dr. Matthias von Herrath joins us to discuss his work at the La Jolla Institute for Immunology and at pharmaceutical company Novo Nordisk. He discusses one of his recently published papers, "Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial".  Full paper link: <a href="https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00019-X/fulltext" rel="nofollow" target="_blank">https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00019-X/fulltext</a>

Episode 70: Matthias von Herrath, MD, Professor at the La Jolla Institute for Immunology and Vice President and Senior Medical Officer at Novo Nordisk

Dr. Matthias von Herrath is committed to clinical translation of immune-based interventions in autoimmune and metabolic diseases, the latter in particular being an exciting emerging field. His expertise and main strength is working at the interface of experimental research to interpret and refine early phase I/II clinical trials in order to optimize strategies for phase 3 trials and drug approval. This comprises translation from various animal models to human interventions, optimization of immunotherapies and their relative ranking, assessment of combination therapies, development of biomarkers as primary or secondary outcomes, induction of antigen specific tolerance in autoimmunity, regulatory cells and clinical T cell assays. In order to be better able to pursue his goal of clinical translation, Dr. von Herrath accepted the position of Vice President and Head of NovoNordisk’s diabetes R&amp;D Center in Seattle in autumn of 2011. At NovoNordisk, he built the diabetes translational unit, which is based on less conventional and innovative design.Understanding disease pathology remains very close to Dr. von Herrath’s heart and NovoNordisk enabled him to keep an appointment at La Jolla Institute, where he pursues NIH-funded research on the pathology of type 1 and 2 diabetes as part of the national pancreatic organ donor network (nPOD). This is a multinational collaborative effort where data are shared in real time and no intellectual property yet lots of new knowledge on the pathology of type 1 and 2 diabetes is being generated. It is a unique new collaborative paradigm for academic and also industry settings.https://www.lji.org/news-events/news/post/lji-professor-named-worlds-leading-type-1-diabetes-expert/https://www.lji.org/news-events/news/post/qa-with-dr-matthias-von-herrath/https://www.youtube.com/watch?v=PznVEXcL5Lk&amp;t=58s-------------Welcome to the Pardon My Pancreas podcast!! This show is all about the REAL life with diabetes. Your two host are Matt Vande Vegte &amp; Ali Abdulkareem. Both type 1 diabetics, both diabetes advocates, both diabetes content creators. Matt is the man behind the brand at FTF Warrior which is an tribe dedicated to helping people living with diabetes achieve a healthier life through online coaching while Ali is the creator of the Diabetes Daily Hustle from the Youtube vlogs and podcast show! This episode is sponsored by FTF Warrior. An online community for diabetics dedicated to helping people live a healthier life! https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/Youtube: https://www.youtube.com/channel/UCCCzwLc-MTNk9636tQyXuwQ---------------------------Follow Ali here:Instagram: https://www.instagram.com/ali.abdlkareem/Youtube: https://www.youtube.com/channel/UCOgPM9FFVTOX5gN_qnVHRNA---------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes managementMusic: https://soundcloud.com/joakimkarud

Dr. Matthias von Herrath is committed to clinical translation of immune-based interventions in autoimmune and metabolic diseases, the latter in particular being an exciting emerging field. His expertise and main strength is working at the interface of experimental research to interpret and refine early phase I/II clinical trials in order to optimize strategies for phase 3 trials and drug approval. This comprises translation from various animal models to human interventions, optimization of immunotherapies and their relative ranking, assessment of combination therapies, development of biomarkers as primary or secondary outcomes, induction of antigen specific tolerance in autoimmunity, regulatory cells and clinical T cell assays. In order to be better able to pursue his goal of clinical translation, Dr. von Herrath accepted the position of Vice President and Head of NovoNordisk’s diabetes R&amp;D Center in Seattle in autumn of 2011. At NovoNordisk, he built the diabetes translational unit, which is based on less conventional and innovative design.Understanding disease pathology remains very close to Dr. von Herrath’s heart and NovoNordisk enabled him to keep an appointment at La Jolla Institute, where he pursues NIH-funded research on the pathology of type 1 and 2 diabetes as part of the national pancreatic organ donor network (nPOD). This is a multinational collaborative effort where data are shared in real time and no intellectual property yet lots of new knowledge on the pathology of type 1 and 2 diabetes is being generated. It is a unique new collaborative paradigm for academic and also industry settings. <a href="https://www.lji.org/news-events/news/post/lji-professor-named-worlds-leading-type-1-diabetes-expert/" rel="nofollow" target="_blank">https://www.lji.org/news-events/news/post/lji-professor-named-worlds-leading-type-1-diabetes-expert/</a> <a href="https://www.lji.org/news-events/news/post/qa-with-dr-matthias-von-herrath/" rel="nofollow" target="_blank">https://www.lji.org/news-events/news/post/qa-with-dr-matthias-von-herrath/</a> <a href="https://www.youtube.com/watch?v=PznVEXcL5Lk&amp;t=58s" rel="nofollow" target="_blank">https://www.youtube.com/watch?v=PznVEXcL5Lk&amp;t=58s</a> ------------- Welcome to the Pardon My Pancreas podcast!! This show is all about the REAL life with diabetes. Your two host are Matt Vande Vegte &amp; Ali Abdulkareem. Both type 1 diabetics, both diabetes advocates, both diabetes content creators. Matt is the man behind the brand at FTF Warrior which is an tribe dedicated to helping people living with diabetes achieve a healthier life through online coaching while Ali is the creator of the Diabetes Daily Hustle from the Youtube vlogs and podcast show!  This episode is sponsored by FTF Warrior. An online community for diabetics dedicated to helping people live a healthier life!  <a href="https://www.ftfwarrior.com" rel="nofollow" target="_blank">https://www.ftfwarrior.com</a> Follow Matt here: Instagram: <a href="https://www.instagram.com/ftfwarrior/" rel="nofollow" target="_blank">https://www.instagram.com/ftfwarrior/</a> Facebook: <a href="https://www.facebook.com/ftfwarrior/" rel="nofollow" target="_blank">https://www.facebook.com/ftfwarrior/</a> Youtube: <a href="https://www.youtube.com/channel/UCCCzwLc-MTNk9636tQyXuwQ" rel="nofollow" target="_blank">https://www.youtube.com/channel/UCCCzwLc-MTNk9636tQyXuwQ</a> --------------------------- Follow Ali here: Instagram: <a href="https://www.instagram.com/ali.abdlkareem/" rel="nofollow" target="_blank">https://www.instagram.com/ali.abdlkareem/</a> Youtube: <a href="https://www.youtube.com/channel/UCOgPM9FFVTOX5gN_qnVHRNA" rel="nofollow" target="_blank">https://www.youtube.com/channel/UCOgPM9FFVTOX5gN_qnVHRNA</a> --------------------------- Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management Music: <a href="https://soundcloud.com/joakimkarud" rel="nofollow" target="_blank">https://soundcloud.com/joakimkarud</a>

Meet The Scientist! Matthias von Herrath

Matthias Von Herrath, MD, Professor, Division of Developmental Immunology, Director, Center for Type 1 Diabetes Research,La Jolla Institute for Allergy and Immunology, Vice President &amp; Head, Diabetes R&amp;D Center, Novo Nordisk Inc. “The Pathology of Human Type 1 Diabetes”

Matthias Von Herrath, MD, Professor, Division of Developmental Immunology, Director, Center for Type 1 Diabetes Research, La Jolla Institute for Allergy and Immunology, Vice President &amp; Head, Diabetes R&amp;D Center, Novo Nordisk Inc. “The Pathology of Human Type 1 Diabetes”

The Pathology of Human Type 1 Diabetes f/ Matthias Von Herrath, MD (10/06/16)